Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.
Identifieur interne : 000144 ( Main/Exploration ); précédent : 000143; suivant : 000145Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.
Auteurs : Amir Goren [États-Unis] ; Craig Roberts ; Timothy W. VictorSource :
- Expert review of vaccines [ 1744-8395 ] ; 2014.
Descripteurs français
- KwdFr :
- Acceptation des soins par les patients (MeSH), Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Brésil (MeSH), Femelle (MeSH), Humains (MeSH), Infections à pneumocoques (immunologie), Infections à pneumocoques (prévention et contrôle), Jeune adulte (MeSH), Mâle (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination (statistiques et données numériques), Vaccins antipneumococciques (administration et posologie), Vaccins antipneumococciques (immunologie).
- MESH :
- administration et posologie : Vaccins antipneumococciques.
- immunologie : Infections à pneumocoques, Vaccins antipneumococciques.
- prévention et contrôle : Infections à pneumocoques.
- statistiques et données numériques : Vaccination.
- Acceptation des soins par les patients, Adolescent, Adulte, Adulte d'âge moyen, Brésil, Femelle, Humains, Jeune adulte, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Brazil (MeSH), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Patient Acceptance of Health Care (MeSH), Pneumococcal Infections (immunology), Pneumococcal Infections (prevention & control), Pneumococcal Vaccines (administration & dosage), Pneumococcal Vaccines (immunology), Vaccination (statistics & numerical data), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Pneumococcal Vaccines.
- immunology : Pneumococcal Infections, Pneumococcal Vaccines.
- prevention & control : Pneumococcal Infections.
- statistics & numerical data : Vaccination.
- Adolescent, Adult, Aged, Aged, 80 and over, Brazil, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Young Adult.
Abstract
This study investigated predictors of pneumococcal polysaccharide vaccine (PPV) use among older adults in Brazil. Respondents aged ≥50 from 2011 National Health and Wellness Survey in Brazil who had ever (vs never) received PPV were compared on comorbid risk, sociodemographics and vaccination behaviors. Logistic regression and decision tree analyses predicted PPV receipt as a function of the measures. Among 3195 respondents, 8.7% reported ever receiving PPV (10.4% among those at risk). Adjusting for covariates, adults classified as high or moderate risk had significantly greater odds of pneumococcal vaccination (odds ratios [ORs]: 2.42 or 1.36, respectively), as were those who received flu vaccinations (OR: 2.21) or were parents/guardians of a vaccinated child (OR: 6.48). In Brazil, child vaccination appears to be the dominant predictor of adult PPV uptake, followed by influenza vaccination. Higher disease risk was a significant predictor, but most older at-risk adults (89.6%) did not receive PPV.
DOI: 10.1586/14760584.2014.863714
PubMed: 24308584
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.</title><author><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Health Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Roberts, Craig" sort="Roberts, Craig" uniqKey="Roberts C" first="Craig" last="Roberts">Craig Roberts</name></author><author><name sortKey="Victor, Timothy W" sort="Victor, Timothy W" uniqKey="Victor T" first="Timothy W" last="Victor">Timothy W. Victor</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24308584</idno><idno type="pmid">24308584</idno><idno type="doi">10.1586/14760584.2014.863714</idno><idno type="wicri:Area/Main/Corpus">000145</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000145</idno><idno type="wicri:Area/Main/Curation">000145</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000145</idno><idno type="wicri:Area/Main/Exploration">000145</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.</title><author><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Health Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Roberts, Craig" sort="Roberts, Craig" uniqKey="Roberts C" first="Craig" last="Roberts">Craig Roberts</name></author><author><name sortKey="Victor, Timothy W" sort="Victor, Timothy W" uniqKey="Victor T" first="Timothy W" last="Victor">Timothy W. Victor</name></author></analytic><series><title level="j">Expert review of vaccines</title><idno type="eISSN">1744-8395</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Brazil (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Acceptance of Health Care (MeSH)</term><term>Pneumococcal Infections (immunology)</term><term>Pneumococcal Infections (prevention & control)</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Pneumococcal Vaccines (immunology)</term><term>Vaccination (statistics & numerical data)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par les patients (MeSH)</term><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Brésil (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à pneumocoques (immunologie)</term><term>Infections à pneumocoques (prévention et contrôle)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antipneumococciques (administration et posologie)</term><term>Vaccins antipneumococciques (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à pneumocoques</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Pneumococcal Infections</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à pneumocoques</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Brazil</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par les patients</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Brésil</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study investigated predictors of pneumococcal polysaccharide vaccine (PPV) use among older adults in Brazil. Respondents aged ≥50 from 2011 National Health and Wellness Survey in Brazil who had ever (vs never) received PPV were compared on comorbid risk, sociodemographics and vaccination behaviors. Logistic regression and decision tree analyses predicted PPV receipt as a function of the measures. Among 3195 respondents, 8.7% reported ever receiving PPV (10.4% among those at risk). Adjusting for covariates, adults classified as high or moderate risk had significantly greater odds of pneumococcal vaccination (odds ratios [ORs]: 2.42 or 1.36, respectively), as were those who received flu vaccinations (OR: 2.21) or were parents/guardians of a vaccinated child (OR: 6.48). In Brazil, child vaccination appears to be the dominant predictor of adult PPV uptake, followed by influenza vaccination. Higher disease risk was a significant predictor, but most older at-risk adults (89.6%) did not receive PPV. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24308584</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8395</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Expert review of vaccines</Title><ISOAbbreviation>Expert Rev Vaccines</ISOAbbreviation></Journal><ArticleTitle>Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.</ArticleTitle><Pagination><MedlinePgn>175-84</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1586/14760584.2014.863714</ELocationID><Abstract><AbstractText>This study investigated predictors of pneumococcal polysaccharide vaccine (PPV) use among older adults in Brazil. Respondents aged ≥50 from 2011 National Health and Wellness Survey in Brazil who had ever (vs never) received PPV were compared on comorbid risk, sociodemographics and vaccination behaviors. Logistic regression and decision tree analyses predicted PPV receipt as a function of the measures. Among 3195 respondents, 8.7% reported ever receiving PPV (10.4% among those at risk). Adjusting for covariates, adults classified as high or moderate risk had significantly greater odds of pneumococcal vaccination (odds ratios [ORs]: 2.42 or 1.36, respectively), as were those who received flu vaccinations (OR: 2.21) or were parents/guardians of a vaccinated child (OR: 6.48). In Brazil, child vaccination appears to be the dominant predictor of adult PPV uptake, followed by influenza vaccination. Higher disease risk was a significant predictor, but most older at-risk adults (89.6%) did not receive PPV. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goren</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Timothy W</ForeName><Initials>TW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Vaccines</MedlineTA><NlmUniqueID>101155475</NlmUniqueID><ISSNLinking>1476-0584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24308584</ArticleId><ArticleId IdType="doi">10.1586/14760584.2014.863714</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><noCountry><name sortKey="Roberts, Craig" sort="Roberts, Craig" uniqKey="Roberts C" first="Craig" last="Roberts">Craig Roberts</name><name sortKey="Victor, Timothy W" sort="Victor, Timothy W" uniqKey="Victor T" first="Timothy W" last="Victor">Timothy W. Victor</name></noCountry><country name="États-Unis"><region name="État de New York"><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeBresilV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000144 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000144 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeBresilV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24308584
|texte= Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24308584" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeBresilV2
| This area was generated with Dilib version V0.6.36. |  |